2012-11-26
(WASHINGTON)-The American Society of Hematology (ASH) announces the recipients of its 2013 Scholar Awards. The ASH Scholar Awards provide monetary support for fellows and junior faculty pursuing research careers to assist them during the critical period in which they must complete their training and achieve status as an independent investigator.
The awards, in the amount of $100,000 for fellows and $150,000 for junior faculty over a two- to three-year period, are made possible through grants from the corporate community, individual donors, foundations, and funds committed by the Society. The Society gratefully recognizes this year’s corporate supporters, which include Amgen; Bristol-Myers Squibb; Celgene Corporation; Gilead Sciences, Inc.; Novartis Pharmaceuticals; Novo Nordisk, Inc.; Onyx Pharmaceuticals; Otsuka America Pharmaceutical, Inc.; Seattle Genetics; and Teva Oncology. ASH is especially appreciative of Millennium: The Takeda Oncology Company for its lead support this year in the amount of $1 million.
“The ASH Scholar Awards represent the Society’s strong history of commitment to supporting hematology research, which is particularly critical during the challenging current economic climate and threatened funding cuts to the National Institutes of Health,” said ASH President Armand Keating, MD, of Princess Margaret Cancer Centre, University Health Network in Toronto. “We thank our partners for their support of this program, which will help foster the next generation of hematology researchers.”
The 2013 Scholar Award recipients are:
Basic Research Fellows
Caroline Arber, MD
Baylor College of Medicine
|
Leon Kautz, PhD
University of California-Los Angeles |
Brian Branchford, MD
University of Colorado |
Vikram Paralkar, MD
University of Pennsylvania |
Jarrod Dudakov, PhD
Memorial Sloan-Kettering Cancer Center |
Raajit Rampal, MD, PhD
Memorial Sloan-Kettering Cancer Center |
Giusy Della Gatta, PhD
Columbia University |
Owen Tamplin, PhD
Boston Children’s Hospital |
Charles Gawad, MD
Stanford University |
Hong Zheng, MD, PhD
Yale University |
Linda Holmfeldt, PhD
St. Jude Children’s Research Hospital |
|
Clinical Research Fellows
Saar Gill, PhD
Hospital of the University of Pennsylvania
|
Loretta Nastoupil, MD
Emory University |
Basic Junior Faculty
Weikai Li, PhD
Washington University in St. Louis |
Jean-Francois Raul, PhD
University of Michigan |
Troy Lund, MD, PhD
University of Minnesota |
Dhvanit Shah, PhD
Brigham and Women’s Hospital |
Anupama Narla, MD
Dana-Farber Cancer Institute |
Laurie Steiner, MD
University of Rochester |
Eirini Papapetrou, MD, PhD
University of Washington |
Jieqing Zhu, PhD
BloodCenter of Wisconsin |
Clinical Junior Faculty
Alan Hanash, MD, PhD
Memorial Sloan-Kettering Cancer Center |
Anita Rajasekhar, MD
University of Florida |
Catherine Smith, MD
University of California-San Francisco |
|
Joanne Levy, MD, Memorial Award for Outstanding Achievement
Karen L. Bunting, PhD, a postdoctoral associate in the Department of Medicine/Hematology-Medical Oncology at Weill Cornell Medical College in New York, will receive the 2013 Joanne Levy, MD, Memorial Award for Outstanding Achievement. This award, made possible by the family of past ASH Scholar Award recipient and distinguished Society member Joanne Levy who passed away in 2004, is given to the current ASH Scholar with the highest scoring abstract at the ASH annual meeting, as determined by the appointed abstract reviewers.
Dr. Bunting’s award will provide funding for her to continue her current laboratory research examining the mechanisms of nuclear organization during B-cell development and lymphomagenesis. Most of Dr. Bunting’s research has focused on chromatin organization and the molecular mechanisms underlying gene regulation in cells of the immune system.
Her previous research has focused on the pathogenesis of hemorrhagic forms of dengue virus, mechanisms of GM-CSF receptor signaling, and the role and function of the NF-κB transcription factor, c-Rel, in inducible T-cell gene transcription.
Dr. Bunting received her PhD from The John Curtain School of Medical Research at The Australian National University in Canberra.
Reporter inquiries may be directed to Andrea Slesinski, ASH Communications Manager, at aslesinski@hematology.org or 202-552-4927.
The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. The official journal of ASH is Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online.
back to top
